|
Gufic BioSciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
3526.94 Cr.
|
P/BV
|
6.14
|
Book Value (Rs.)
|
57.26
|
|
52 Week High/Low (Rs.)
|
498/299
|
FV/ML
|
1/1
|
P/E(X)
|
50.64
|
|
Bookclosure
|
22/09/2025
|
EPS (Rs.)
|
6.95
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
| FaceValue | 1.00 | 1.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 745.55 | 769.66 |
| Other Operating Revenues | 74.25 | 37.01 |
| Total Operating Revenues | 819.81 | 806.67 |
| | | |
| Other Income | 3.63 | 2.18 |
| Total Revenue | 823.43 | 808.84 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 344.20 | 331.26 |
| Purchase Of Stock-In Trade | 55.41 | 58.06 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -24.91 | 0.57 |
| Employee Benefit Expenses | 127.19 | 109.63 |
| Finance Costs | 24.52 | 15.36 |
| Depreciation And Amortisation Expenses | 21.06 | 17.02 |
| Other Expenses | 181.82 | 161.27 |
| Total Expenses | 729.29 | 693.17 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 94.14 | 115.67 |
| | | |
| Profit/Loss Before Tax | 94.14 | 115.67 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 18.72 | 28.40 |
| Deferred Tax | 5.75 | 3.17 |
| Tax For Earlier Years | 0.02 | -2.03 |
| Total Tax Expenses | 24.49 | 29.54 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 69.65 | 86.14 |
| | | |
| Profit/Loss From Continuing Operations | 69.65 | 86.14 |
| | | |
| Profit/Loss For The Period | 69.65 | 86.14 |
| Consolidated Profit/Loss After MI And Associates | 69.65 | 86.14 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | 6.95 | 8.74 |
| Diluted EPS (Rs.) | 6.95 | 8.74 |
| | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | |
| Equity Share Dividend | 1.00 | 0.97 |
